Case Studies

Lumbopelvic Instability

Your download will start automatically once you have provided the following information:

“iFuse TORQ facilitates robust fixation, even in the setting of notable osteopenia and instability.”

Malcolm R. DeBaun, MD

*Consultant for SI-BONE, Inc.

Provider
Malcolm R. DeBaun, MD*
Speciality
Director of Orthopaedic Trauma Duke University
Facility
Duke University Hospital
Bio
Fellowship: Orthopaedic Trauma, Harborview Medical Center, Seattle, WA 
Residency: Orthopaedic Surgery, Stanford Un... More

Case Details

Condition
Pelvic Trauma
Product(s)
iFuse TORQ
Patient
76 y/o female

Lumbopelvic Instability after Chronic Sacral U- Fracture

Patient History:
  • Fall 3 months prior
  • Managed non-operatively by outside hospital
  • 10/10 pain; difficulty ambulating  x 3 mo
  • MRI done and self-referral to IR for sacroplasty
  • Referred to ortho by IR for pelvic fixation
Debaun - Lumbopelvic Instability - 1
Debaun - Lumbopelvic Instability - 1
Debaun - Lumbopelvic Instability - 2
Debaun - Lumbopelvic Instability - 2
Diagnosis:
  • Chronic Sacral U-type fracture with kyphotic deformity
  • Anterior ring disruption
  • Osteopenia
Debaun - Lumbopelvic Instability - 3
Debaun - Lumbopelvic Instability - 3
Debaun - Lumbopelvic Instability - 4
Debaun - Lumbopelvic Instability - 4
Surgical treatment:
  • Bilateral sacral fracture fixation with iFuse TORQ®
Post-op:1,2
  • Tolerated procedure well
  • Immediate weight bearing as tolerated
  • Ambulated 150 feet POD 1 and discharged home
  • Pain improvement and healed fracture at 2 months
  • No progression of kyphotic deformity
Debaun - Lumbopelvic Instability - 5
Debaun - Lumbopelvic Instability - 5
Debaun - Lumbopelvic Instability - 6
Debaun - Lumbopelvic Instability - 6
Debaun - Lumbopelvic Instability - 7
Debaun - Lumbopelvic Instability - 7
Debaun - Lumbopelvic Instability - 8
Debaun - Lumbopelvic Instability - 8
Debaun - Lumbopelvic Instability - 9
Debaun - Lumbopelvic Instability - 9

1Patient results may vary
2Pain and disability improvement consistent with early SAFFRON trial (NCT05426356) outcomes. SI-BONE data on file.

Healthcare professionals should refer to the Instructions For Use for indications, contraindications, warnings, and precautions at https://si-bone.com/label.  

There are potential risks associated with iFuse procedures. They may not be appropriate for all patients and all patients may not benefit.
For information about the risks, visit https://si-bone.com/risks

Looking for Answers?

We can help. Tell us what you're looking for below.